[ALNY] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
14-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- -55.13%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 844,287 492,853 219,750 74,908 89,912 47,159 41,097 65.41%
PBT -852,144 -855,600 -885,253 -760,674 -490,874 -410,108 -290,073 19.65%
Tax 680 2,681 863 823 -25,603 -23,438 -24,909 -
NP -852,824 -858,281 -886,116 -761,497 -490,874 -410,108 -290,073 19.67%
Tax Rate - - - - - - - -
Total Cost 1,697,111 1,351,134 1,105,866 836,405 580,786 457,267 331,170 31.27%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -101.01 -174.15 -403.24 -1,016.58 -545.95 -869.63 -705.83 -27.65%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -7.20 -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 13.03%
EPS Diluted -7.20 -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 13.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.